Skip to content

VIA Disc NP Registry

VIA Disc NP Registry

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04652687
Enrollment
83
Registered
2020-12-03
Start date
2020-05-03
Completion date
2024-03-05
Last updated
2024-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Back Pain, Low, Discogenic Pain

Keywords

back pain

Brief summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Detailed description

The Registry is intended to collect data for patients having received treatment with VIA Disc NP.

Interventions

OTHERVIA Disc NP (HCT/P)

VIA Disc NP - Allograft tissue injection

Sponsors

VIVEX Biologics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Understand and sign the informed consent form (as applicable) * VIA Disc NP injection is scheduled for 1 or more levels

Exclusion criteria

* VIA Disc NP injection is not performed

Design outcomes

Primary

MeasureTime frameDescription
Patient self-reporting of daily function1, 3, 6, 12, 24, & 36 monthsChange in scores from Oswestry Disability Index (ODI). An index comprising of ten categories of function to quantify disability due to back pain.
Patient self-reported back pain1, 3, 6, 12, 24, & 36 monthsChange in Numeric Rating Scale (NRS) scores. Eleven point pain scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).

Secondary

MeasureTime frameDescription
Patient self-reported mental health1, 3, 6, 12, 24, & 36 monthsChange in patient reported anxiety and depression scores. Four question scale used for patient self-reporting of anxiety and depression which ranges from 0-2 (normal), mild (3-5), moderate (6-8), and severe (9-12).
Resource Utilization1, 3, 6, 12, 24, & 36 monthsPatient reported assessment of healthcare and resources utilized questions to treat ongoing back pain post treatment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026